349 results on '"Mineno, Junichi"'
Search Results
2. Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model
3. Adeno-associated virus vector system controlling capsid expression improves viral quantity and quality
4. Preclinical study of a DNA vaccine targeting SARS-CoV-2
5. Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant
6. Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia
7. Applications and Limitations of Equilibrium Density Gradient Analytical Ultracentrifugation for the Quantitative Characterization of Adeno-Associated Virus Vectors
8. T cell receptor gene‐modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft‐versus‐host disease
9. Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
10. Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model
11. CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy
12. Cell and Vector Production Facility for Gene Therapy and Cell Therapy
13. Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS
14. Data from Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy
15. Supplementary Figure 1 from Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy
16. Supplementary Figure 2 from Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy
17. Supplementary Figure S3 from Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
18. Supplementary Figure S1 from Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
19. Supplementary Table S1 from Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
20. Supplementary Table S1 from Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
21. Supplementary Figure Legend from Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
22. Supplementary Figure 2 from Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
23. Supplementary Figure Legends 1-3 from Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
24. Supplementary Figure 3 from Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
25. Supplementary Figure 1 from Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
26. Data from Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
27. Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells
28. Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation
29. Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs
30. Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells
31. Immune response induced in rodents by anti-CoVid19 plasmid DNA vaccine via pyro-drive jet injector inoculation
32. NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome
33. Development of a novel redirected T-cell–based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia
34. Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation
35. Outcomes in Two Japanese Adenosine Deaminase-Deficiency Patients Treated by Stem Cell Gene Therapy with No Cytoreductive Conditioning
36. Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity
37. 103 Quality improvement of anti-CD38-JAK/STAT CAR-T cells by suppressing CD38 expression and inhibition of tyrosine kinase
38. 64 A cloning and expression system of the neoantigen-specific TCRs from tumor-infiltrating lymphocytes by single-cell sequencing of paired TCRα and TCRβ chains
39. Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response
40. Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis
41. hTERT is an immunogenic antigen for a novel gene-immunotherapy against adult T-cell leukemia: OR-57.
42. TUMOR SELECTIVE REPLICATION AND INTERFERON-β SENSITIVITY OF ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 MUTANT HF10: OR-85.
43. EFFICIENT AND SAFE VECTORS FOR TCR GENE THERAPY: SILENCING OF ENDOGENOUS TCR IMPROVED THE EFFICACY AND SAFETY OF TCR GENE THERAPY: OR-58.
44. THE SIMPLE AND QUICK ANALYSIS SYSTEM BASED ON Q-PCR USING CYCLING PROBE THECHNOLOGY FOR QUANTIFICATION OF LENTIVIRAL COPY NUMBERS.: PO-98.
45. ONCOLYTIC VIROTHERAPY FOR OSTEOSARCOMA WITH HERPES SIMPLEX VIRUS TYPE 1 MUTANT HF10: OR-52.
46. ANALYSIS OF TCR GENE TRANSFERRED T CELLS PROCESSED WITH RETRONECTIN®/OKT3 STIMULATION METHOD: OR-59.
47. INHIBITION OF HIV-1 REPLICATION IN ENDORIBONUCLEASE GENE MODIFIED CD4+ T CELLS: OR-72.
48. CCL2-CCR2 axis potentiates the anti-lung cancer reactivity mediated by redirected T cells using WT1-specific TCR gene transfer.: OR-56.
49. Efficient transfer and expression of multiple genes by retroviral vector: S7-5.
50. Anti-CoVid19 plasmid DNA vaccine induces a potent immune response in rodents by Pyro-drive Jet Injector intradermal inoculation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.